Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F18ac fimbriae are proteinaceous surface appendages found on specific strains of enterotoxigenic Escherichia coli (ETEC) that primarily affect swine (PMID: 1550500). These fimbriae are composed of a major subunit, FedA, and a tip adhesin, FedF, which facilitates the attachment of the bacteria to the brush border of porcine enterocytes (UniProt: P24207). This adherence is a prerequisite for the colonization of the small intestine and the subsequent release of enterotoxins, leading to post-weaning diarrhea (PWD) (PMID: 21844312). Because the F18ac variant is highly prevalent in ETEC strains causing significant economic impact in the swine industry, it serves as a critical target for veterinary interventions. Current therapeutic approaches include the use of live-attenuated oral vaccines, such as Coliprotec F18, to stimulate local intestinal immunity and the development of anti-adhesive molecules that block the binding of FedF to host carbohydrate receptors (PMID: 25108000).
Inhibition of bacterial adhesion to intestinal epithelial cells and induction of mucosal immunity through active or passive immunization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F18ac fimbriae (F18ac).